Systematic monitor disinfection is effective in limiting HCV spread in hemodialysis

Blood Purification

Volumn 18, Issue 2, 2000, Pages 110-114

  Aucella, Filippo ^a   Vigilante, Mimmo ^a   Valente, Giuseppe Lucio ^a   Stallone, Carmine ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Hemodialysis, separate machines; Hepatitis C virus; Monitor disinfection; Nosocomial transmission; Universal precautions

Indexed keywords

HEPATITIS C ANTIBODY; HYPOCHLORITE SODIUM; PERACETIC ACID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DISEASE TRANSMISSION; DISINFECTION; FEMALE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION CONTROL; MALE; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; SEROCONVERSION; TIME;

EID: 0033853537     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014433     Document Type: Article

References (32)

1. Alter MJ, Hadler SC, Judson FN, et al: Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990;264:2231-2235.
2. Knudsen F, Wantzin P, Rasmussen K, Lagefoged SD, Lokkegaard N, Rasmussen LS, Lassen A, Krogsgaard K: Hepatitis C in dialysis patients: Relationship to blood transfusions, dialysis and liver disease. Kidney Int 1993;43: 1353-1356.
3. Fabrizi F, Bacchini G, Pontoriero G, Guarnori I, Erba GF, Locatelli F: Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic haemodialysis patients: A study with second generation assays. Nephrol Dial Transplant 1993;8:744-747.
4. Jadoul M: Transmission routes of HCV infection in dialysis. Nephrol Dial Transplant 1996; 11(suppl 4):36-38.
5. Aucella F, Del Giudice AM, Scarlatella A, Di Tullio M, et al: Effectiveness of universal precautions in limiting nosocomial transmission of hepatitis C virus infection in haemodialysis units. Int J Artif Organs 1996;19:435-436.
6. Fabrizi F, Lunghi G, Guarnori I, Lugano R, Crepaldi M, Pagano A, Locatelli F: Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: A prospective study. Nephrol Dial Transplant 1994;9:1611-1615.
7. Jadoul M, Cornu C, van Ypersele de Strihoh C: Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study. The UCL Collaborative Group. Kidney Int 1993;44:1322-1326.
8. Chant K, Kociuba K, Munro R, et al: Investigation of possible patient to patient transmission of hepatitis C in a hospital. NSW Publ Health Bull 1994;5:47-51.
9. Allander T, Medin C, Jacobson SH, et al: Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995;345:603-607.
10. Allander T, Medin C, Jacobson SH, et al: Hepatitis C transmission in a hemodialysis unit: Molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994;43:415-419.
11. Imberti L, Cariani E, Bettinardi A, Zonaro A, et al: An immunoassay for specific amplified HCV sequences. J Virol Methods 1991;34: 233-243.
12. Leads from the MMWR: Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in healthcare settings. JAMA 1988;260:462-465.
13. Aucella F, Centra M, Gesuete A, et al: Prevalence and clinical relevance of hepatitis C virus viraemia in patients on chronic hemodialysis. J Nephrol 1996;2:88-92.
14. Geerlings W, Tufveson G, Ehrich JHH, et al: Report on management of renal failure in Europe, XXIII. Nephrol Dial Transplant 1994; 9(suppl 1):6-25.
15. Valderrabano F, Jones EHP, Mallick NP: Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant 1995; 10(suppl 5):1-25.
16. Niu M, Alter MJ, Kristensen C, Margolis HS: Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus. Am J Kidney Dis 1992;19: 345-352.
17. Sampietro M, Badalamenti S, Salvadori S, Corbetta N, Graziani G, Como G, Fiorelli G, Ponticelli C: High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: Evidence for nosocomial transmission of HCV. Kidney Int 1995;47:911-917.
18. Pol S, Romeo R, Zins B, Driss F, Lebkiri B, Carnot F, Berthelot P, Brechot C: Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: Significance and therapeutic implications. Kidney Int 1993;44:1097-1100.
19. Calabrese G, Vagelli G, Guaschino R, Gonella M: Transmission of anti-HCV within the household of haemodialysis patients. Lancet 1991;338:1466.
20. Tremolada F, Casarin C, Tagger A, Ribero ML, Realdi G, Alberti A, Ruol A: Antibody to hepatitis C virus in post-transfusion hepatitis. Ann Intern Med 1991;114:277-281.
21. Cuypers HTM, Winkel IN, van der Poel CL, Reesink HW, Lelie PN, Houghton M, Weiner A: Analysis of genomic variability of hepatitis C virus. J Hepatol 1991;13(suppl 4):15-19.
22. Pereira BJG, Levey AS: Hepatitis C virus infection in dialysis and in renal transplantation. Kidney Int 1997;51:981-999.
23. Garcia Valdecasas G, Bernal CM, Garcia F, Montiel A, Navas Parejo A, Cerezo S: Hepatitis C in hemodialysis: Preventive protocol throughout 3 years (abstract). EDTA-ERA 1993, p 970.
24. Pinto Dos Santos J, Loureiro A, Cendoroglo M, Pereira BJG: Impact of dialysis room and reuse strategies on the incidence of HCV infection in HD units. Nephrol Dial Transplant, in press.
25. Lombardi M, Cerrai T, Dattolo P, et al: Is the dialysis membrane a safe barrier against HCV infection? Nephrol Dial Transplant 1995;10: 578.
26. Valtuille R, Fernandez JL, Berridi J, et al: Evidence of hepatitis C virus passage across dialysis membrane. Nephron 1998;80:194-196.
27. McLaughklin KJ, Cameron SO, Good T, McCruden E, et al: Nosocomial transmission of hepatitis C virus within a British dialysis centre. Nephrol Dial Transplant 1997;12:304-309.
28. Forns X, Fernandez-Llama P, Pons M, Costa J, et al: Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit. Nephrol Dial Transplant 1997;12:736-740.
29. Chiaramonte S, Tagger A, Ribero LM, Grossi A, Milan M, La Greca G: Prevention of viral hepatitis in dialysis units: Isolation and technical management of dialysis. Nephron 1992;61: 287-289.
30. Gilli P, Moretti M, Soffritti S, et al: Non a-Non b hepatitis and HCV antibodies in dialysis patients. Int J Artif Organs 1990;13:737-741.
31. Gilli P, Soffritti S, De Paoli Vitali E, Bedani PL: Prevention of hepatitis C virus within dialysis units. Nephron 1995;70:301-306.
32. Alter MJ, Favero MS, Moyer LA, Bland LA: National surveillance of dialysis associated diseases in the United States 1989. ASAIO Trans 1991;37:97-109.